Published in Vaccine Weekly, February 27th, 1995
An increased production of influenza virus-specific antibodies has been detected in in vitro cultures of peripheral blood lymphocytes collected one week after vaccination.
Researcher Karl A. Brokstad and colleagues previously observed a similar trend, but the high level of influenza virus-specific antibody-secreting cells (ASC) in peripheral blood was short-lived and after two to three weeks returned to prevaccination...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1995-02-27)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.